News
US President Trump had earlier suggested pharmaceutical tariffs could reach 200% after a year, incentivizing domestic manufacturing. On Tuesday, he said that an agreement with India was among the most ...
4h
Zacks Investment Research on MSNMerck (MRK) Falls More Steeply Than Broader Market: What Investors Need to KnowMerck (MRK) closed the most recent trading day at $81.52, moving -2.57% from the previous trading session. This change lagged the S&P 500's 0.4% loss on the day. Meanwhile, the Dow experienced a drop ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
Private equity work is up year-over-year, but tariffs, inflation and valuations continue to be an issue for dealmakers.
TOKYO -- Roughly 2.5 million doses of oral COVID-19 medication bought by the Japanese government during the pandemic expired ...
Merck & Co., Inc. (NYSE:MRK), one of the largest pharmaceutical companies in the world, has lost 15% year-to-date on the ...
Dragged down by declines for shares of American Express and Merck, the Dow Jones Industrial Average is falling Tuesday afternoon.
Merck, a leading science and technology company, has launched the AAW™ Automated Assay Workstation, a solution powered by ...
NHS England has agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced its once-monthly PrEP ...
A report on July 14, 2025 shows that Representative Julie Johnson from Texas purchase stock in 3M MMM -0.70% Get Free Report , valued between $2,002 and $30,000. According to the July filing, the ...
12h
Stocktwits on MSNAdagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns OptimisticAdagene Inc. (ADAG) on Tuesday said that it received directions from the U.S. Food and Drug Administration on further clinical development of its investigational drug Muzastotug in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results